At Bendable Therapy, we are conducting Oregon’s first field study on psilocybin-assisted therapy. This research aims to evaluate its impact on mental health conditions such as depression, anxiety, and PTSD. Our commitment to scientific excellence and transparency ensures that our findings will significantly contribute to the understanding and development of effective mental health treatments.

Our collaboration with Osmind enhances the depth and scope of our research. By leveraging their expertise in mental health data analytics, we are able to gather and interpret data more effectively, ensuring robust and reliable results.

This partnership allows us to explore new dimensions of psychedelic-assisted therapy, providing insights that are critical to advancing mental health care practices.

At Bendable Therapy, transparency and scientific rigor are the cornerstones of our research initiatives. We are dedicated to open communication, ensuring that our methodologies and findings are accessible to the public and the scientific community alike. By adhering to the highest standards of research integrity, we aim to foster trust and contribute meaningful insights to the field of mental health care.

Our commitment to transparency involves sharing our research processes and results with stakeholders, including participants, collaborators, and the broader community. We believe that by openly discussing our methods and outcomes, we can enhance public understanding and support the development of safe and effective therapeutic practices.

 The 2024 Annual Report from Bendable Therapy offers a comprehensive review of our achievements and challenges over our first year in existence. We received 429 applications of which 408 clients consent to participating in this survey.  60% of applications were from Oregon and of those, 65% were from Central Oregon.

Among our applicants, 53% identified as women (44% as men and 3% as nonbinary), 54% were under 50 years of age and 46% were over 50, and 11% served in the Armed Forces.